[ad_1]
AstraZeneca’s Austrian head advocates approving the vaccine for people over 65. There will be reliable data on this soon. The vaccine should also work against mutations.
The prelude to approval of AstraZeneca’s Covid vaccine was difficult. Although the British-Swedish pharmaceutical company vaccine passed the strict approval test of the European Medicines Agency (EMA), the recommendation of the Austrian National Vaccination Board came on Sunday to (for now) only vaccinate the vaccine to minors 65 years.
A decision that Sarah Walters, director of AstraZeneca in Austria, cannot understand. She fights back to defend her own vaccine against the doom prophecies of the last days. “We would have liked admission for everyone over 18 years of age. In the 65-year-old age group, the safety and immunogenicity data are comparable to those of the 18-64 year-olds. “Many see it differently. The reason for the decision of the National Vaccination Board was that there is hardly any reliable data on efficacy in people over 65 years of age.
